Literature DB >> 26615899

What do we know about brain contrast enhancement patterns in neuromyelitis optica?

Yeliz Pekcevik1, Gunes Orman2, In Ho Lee3, Maureen A Mealy4, Michael Levy5, Izlem Izbudak6.   

Abstract

Neuromyelitis optica (NMO) is an autoimmune disorder of the central nervous system that usually presents with acute myelitis and/or optic neuritis. Recently, some brain magnetic resonance imaging findings have been described in NMO that are important in the differential diagnosis. Pencil-thin, leptomeningeal, and cloud-like enhancement may be specific to NMO. These patterns are usually seen during relapses. Recognizing these lesions and enhancement patterns may expedite the diagnosis and allows early effective treatment. The purpose of this article is to review the latest knowledge and to share our experience with the contrast enhancement patterns of NMO brain lesions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain; Magnetic resonance imaging; Neuromyelitis optica; neuroimaging

Mesh:

Substances:

Year:  2015        PMID: 26615899      PMCID: PMC4816659          DOI: 10.1016/j.clinimag.2015.07.027

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  42 in total

1.  Intractable vomiting as the initial presentation of neuromyelitis optica.

Authors:  Metha Apiwattanakul; Bogdan F Popescu; Marcelo Matiello; Brian G Weinshenker; Claudia F Lucchinetti; Vanda A Lennon; Andrew McKeon; Adam F Carpenter; Gary M Miller; Sean J Pittock
Journal:  Ann Neurol       Date:  2010-11       Impact factor: 10.422

2.  Acute reversible periependymal ventricular enhancement in neuromyelitis optica.

Authors:  C A McGraw; M L Swerdlow; M S Robbins
Journal:  Eur J Neurol       Date:  2012-06       Impact factor: 6.089

3.  Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression.

Authors:  Sean J Pittock; Brian G Weinshenker; Claudia F Lucchinetti; Dean M Wingerchuk; John R Corboy; Vanda A Lennon
Journal:  Arch Neurol       Date:  2006-07

4.  Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?

Authors:  Jonathan James Downer; Maria Isabel Leite; Ranjana Carter; Jacqueline Palace; Wilhelm Küker; Gerardine Quaghebeur
Journal:  Neuroradiology       Date:  2011-05-07       Impact factor: 2.804

5.  Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.

Authors:  Youming Long; Mengyu Chen; Bin Zhang; Cong Gao; Yangbo Zheng; Longchang Xie; Qingchun Gao; Jianrui Yin
Journal:  J Neuroimmunol       Date:  2014-02-16       Impact factor: 3.478

6.  Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.

Authors:  S M Magaña; M Matiello; S J Pittock; A McKeon; V A Lennon; A A Rabinstein; E Shuster; O H Kantarci; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

7.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

Review 8.  Magnetic resonance imaging in neuromyelitis optica.

Authors:  George Tackley; Wilhelm Kuker; Jacqueline Palace
Journal:  Mult Scler       Date:  2014-05-14       Impact factor: 6.312

9.  "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica.

Authors:  Shoichi Ito; Masahiro Mori; Takahiro Makino; Sei Hayakawa; Satoshi Kuwabara
Journal:  Ann Neurol       Date:  2009-09       Impact factor: 10.422

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  8 in total

1.  [Inflammatory diseases of the central nervous system].

Authors:  Armin Bachhuber
Journal:  Radiologe       Date:  2021-06-08       Impact factor: 0.635

Review 2.  Brain miliary enhancement.

Authors:  Joseph C J Bot; Linda Mazzai; Rogier E Hagenbeek; Silvia Ingala; Bob van Oosten; Esther Sanchez-Aliaga; Frederik Barkhof
Journal:  Neuroradiology       Date:  2020-01-10       Impact factor: 2.804

Review 3.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

Review 4.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

5.  Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.

Authors:  G Orman; K Y Wang; Y Pekcevik; C B Thompson; M Mealy; M Levy; I Izbudak
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-16       Impact factor: 3.825

6.  Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review.

Authors:  Kevin Yuqi Wang; Justin Chetta; Pavit Bains; Anthony Balzer; John Lincoln; Tomas Uribe; Christie M Lincoln
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

7.  Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Authors:  Nasrin Asgari; Eoin P Flanagan; Kazuo Fujihara; Ho Jin Kim; Hanne P Skejoe; Jens Wuerfel; Hiroshi Kuroda; Su Hyun Kim; Elisabeth Maillart; Romain Marignier; Sean J Pittock; Friedemann Paul; Brian G Weinshenker
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-04-21

8.  Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

Authors:  Velina S Chavarro; Maureen A Mealy; Alexandra Simpson; Anna Lacheta; Florence Pache; Klemens Ruprecht; Stefan M Gold; Friedemann Paul; Alexander Ulrich Brandt; Michael Levy
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.